Literature DB >> 25755736

Hydrogen sulfide improves cardiomyocytes electrical remodeling post ischemia/reperfusion injury in rats.

Ying-Gang Sun1, Xin-Yan Wang2, Xiu Chen1, Cheng-Xing Shen1, Yi-Gang Li1.   

Abstract

Hydrogen sulfide (H2S), produced by cystanthionine-γ-lysase (CSE) in the cardiovascular system, is an endogenous gaseous mediator exerting pronounced physiological effects as the third gasotransmitter in addition to nitric oxide (NO) and carbon monoxide (CO). Accumulating evidence indicated that H2S could mediate the cardioprotective effects in myocardial ischemia model. Ventricular arrhythmia is the most important risk factor for cardiac mortality and sudden death after acute myocardial infarction (AMI). The potential impact of H2S on cardiomyocytes electrical remodeling post ischemic insult is not fully explored now. Present study investigated the role of H2S on cardiomyocytes electrical remodeling in rats with ischemia/reperfusion injury. H2S concentration was reduced and arrhythmia score was increased in this model. CSE mRNA level was also upregulated in the ischemic myocardium. Exposure to exogenous NaHS reduced the action potential duration (APD), inhibited L-type Ca(2+) channels and activated K(ATP) channels in cardiomyocytes isolated from ischemic myocardium Exogenous H2S application improves electrical remodeling in cardiomyocytes isolated from ischemic myocardium. These results indicated that reduced H2S level might be linked to ischemia/reperfusion induced arrhythmias.

Entities:  

Keywords:  CSE; Hydrogen sulfide; KATP channels; L-type Ca2+ channels; action potential duration; ischemia/reperfusion

Mesh:

Substances:

Year:  2015        PMID: 25755736      PMCID: PMC4348841     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  26 in total

1.  The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat.

Authors:  A Sivarajah; M C McDonald; C Thiemermann
Journal:  Shock       Date:  2006-08       Impact factor: 3.454

Review 2.  Cardiac electrical remodeling in health and disease.

Authors:  Michael J Cutler; Darwin Jeyaraj; David S Rosenbaum
Journal:  Trends Pharmacol Sci       Date:  2011-03       Impact factor: 14.819

3.  Hydrogen sulfide and its possible roles in myocardial ischemia in experimental rats.

Authors:  Yi Zhun Zhu; Zhong Jing Wang; Peiying Ho; Yoke Yun Loke; Yi Chun Zhu; Shan Hong Huang; Chee Sin Tan; Matt Whiteman; Jia Lu; Philip K Moore
Journal:  J Appl Physiol (1985)       Date:  2006-10-12

4.  Genetic and pharmacologic hydrogen sulfide therapy attenuates ischemia-induced heart failure in mice.

Authors:  John W Calvert; Marah Elston; Chad K Nicholson; Susheel Gundewar; Saurabh Jha; John W Elrod; Arun Ramachandran; David J Lefer
Journal:  Circulation       Date:  2010-06-21       Impact factor: 29.690

5.  Endogenous hydrogen sulphide mediates the cardioprotection induced by ischemic postconditioning.

Authors:  Qian Chen Yong; Shiau Wei Lee; Chun Shin Foo; Kay Li Neo; Xin Chen; Jin-Song Bian
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-07-25       Impact factor: 4.733

Review 6.  Novel insights into hydrogen sulfide--mediated cytoprotection.

Authors:  John W Calvert; William A Coetzee; David J Lefer
Journal:  Antioxid Redox Signal       Date:  2010-05-15       Impact factor: 8.401

7.  Hydrogen sulphide is an inhibitor of L-type calcium channels and mechanical contraction in rat cardiomyocytes.

Authors:  Ying-Gang Sun; Yin-Xiang Cao; Wen-Wei Wang; Shan-Feng Ma; Tai Yao; Yi-Chun Zhu
Journal:  Cardiovasc Res       Date:  2008-06-04       Impact factor: 10.787

Review 8.  Hydrogen sulphide and its therapeutic potential.

Authors:  Csaba Szabó
Journal:  Nat Rev Drug Discov       Date:  2007-11       Impact factor: 84.694

9.  Exogenous hydrogen sulfide postconditioning protects isolated rat hearts against ischemia-reperfusion injury.

Authors:  Yong Ji; Qing-feng Pang; Gang Xu; Li Wang; Jun-ke Wang; Yin-ming Zeng
Journal:  Eur J Pharmacol       Date:  2008-04-08       Impact factor: 4.432

10.  Chronic sodium hydrosulfide treatment decreases medial thickening of intramyocardial coronary arterioles, interstitial fibrosis, and ROS production in spontaneously hypertensive rats.

Authors:  Ying-Xian Shi; Ying Chen; Yi-Zhun Zhu; Guo-Ying Huang; Philip Keith Moore; Shan-Hong Huang; Tai Yao; Yi-Chun Zhu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-07-13       Impact factor: 4.733

View more
  6 in total

Review 1.  Emerging role of hydrogen sulfide-microRNA crosstalk in cardiovascular diseases.

Authors:  Bryan T Hackfort; Paras K Mishra
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-01-22       Impact factor: 4.733

2.  H2S and homocysteine control a novel feedback regulation of cystathionine beta synthase and cystathionine gamma lyase in cardiomyocytes.

Authors:  Shyam Sundar Nandi; Paras Kumar Mishra
Journal:  Sci Rep       Date:  2017-06-16       Impact factor: 4.379

Review 3.  ArrhythmoGenoPharmacoTherapy.

Authors:  Arpad Tosaki
Journal:  Front Pharmacol       Date:  2020-05-12       Impact factor: 5.810

Review 4.  Sulfide regulation of cardiovascular function in health and disease.

Authors:  Gopi K Kolluru; Rodney E Shackelford; Xinggui Shen; Paari Dominic; Christopher G Kevil
Journal:  Nat Rev Cardiol       Date:  2022-08-05       Impact factor: 49.421

Review 5.  Hydrogen Sulfide in Physiology and Diseases of the Digestive Tract.

Authors:  Sudha B Singh; Henry C Lin
Journal:  Microorganisms       Date:  2015-11-12

6.  Boosting endogenous production of vasoprotective hydrogen sulfide via supplementation with taurine and N-acetylcysteine: a novel way to promote cardiovascular health.

Authors:  James J DiNicolantonio; James H OKeefe; Mark F McCarty
Journal:  Open Heart       Date:  2017-05-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.